Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Viruses ; 16(5)2024 Apr 25.
Article in English | MEDLINE | ID: mdl-38793551

ABSTRACT

Epstein-Barr Virus (EBV) is closely linked to nasopharyngeal carcinoma (NPC), notably prevalent in southern China. Although type II latency of EBV plays a crucial role in the development of NPC, some lytic genes and intermittent reactivation are also critical for viral propagation and tumor progression. Since T cell-mediated immunity is effective in targeted killing of EBV-positive cells, it is important to identify EBV-derived peptides presented by highly prevalent human leukocyte antigen class I (HLA-I) molecules throughout the EBV life cycle. Here, we constructed an EBV-positive NPC cell model to evaluate the presentation of EBV lytic phase peptides on streptavidin-tagged specific HLA-I molecules. Utilizing a mass spectrometry (LC-MS/MS)-based immunopeptidomic approach, we characterized eleven novel EBV peptides as well as two previously identified peptides. Furthermore, we determined these peptides were immunogenic and could stimulate PBMCs from EBV VCA/NA-IgA positive donors in an NPC endemic southern Chinese population. Overall, this work demonstrates that highly prevalent HLA-I-specific EBV peptides can be captured and functionally presented to elicit immune responses in an in vitro model, which provides insight into the epitopes presented during EBV lytic cycle and reactivation. It expands the range of viral targets for potential NPC early diagnosis and treatment.


Subject(s)
Epstein-Barr Virus Infections , HLA-A2 Antigen , Herpesvirus 4, Human , Nasopharyngeal Carcinoma , Peptides , Humans , Herpesvirus 4, Human/immunology , Herpesvirus 4, Human/genetics , Peptides/immunology , Peptides/chemistry , Epstein-Barr Virus Infections/immunology , Epstein-Barr Virus Infections/virology , HLA-A2 Antigen/immunology , HLA-A2 Antigen/genetics , Nasopharyngeal Carcinoma/immunology , Nasopharyngeal Carcinoma/virology , HLA-A11 Antigen/immunology , HLA-A11 Antigen/genetics , Proteomics/methods , Nasopharyngeal Neoplasms/immunology , Nasopharyngeal Neoplasms/virology , China , Tandem Mass Spectrometry , Epitopes, T-Lymphocyte/immunology , Cell Line, Tumor
2.
Int Rev Neurobiol ; 172: 303-319, 2023.
Article in English | MEDLINE | ID: mdl-37833016

ABSTRACT

Glioma is the most common primary central nervous tumor and its malignant and high recurrence rate are seriously threatening patient's life. The prognosis of glioma patients is still poor with a variety of modern treatments. Traditional Chinese medicine (TCM) is widely used in the adjuvant treatment or alternative medicine of glioma. Curcumae Rhizoma is one of the most commonly used in traditional Chinese medicine prescriptions for its anti-tumor characteristics. There are also many studies that reveals the anti-tumor effect of its active ingredients and some of which have been made into drugs and have been used in clinical practice. This review summarizes the new research progress on Curcumae Rhizoma for the treatment of glioma in recent years.


Subject(s)
Drugs, Chinese Herbal , Glioma , Humans , Medicine, Chinese Traditional , Drugs, Chinese Herbal/therapeutic use , Curcuma , Rhizome , Glioma/drug therapy
3.
BMC Pregnancy Childbirth ; 20(1): 604, 2020 Oct 08.
Article in English | MEDLINE | ID: mdl-33032548

ABSTRACT

BACKGROUND: Pregnancy tests can be used for the early diagnosis of fetal problems and can prevent abnormal birth in pregnancies. Yet, testing preferences among Chinese women are poorly investigated. METHODS: We developed a Discrete Choice Experiment with 5 attributes: test procedure, detection rate, miscarriage rate, time to wait for result, and test cost. By studying the choices that the women make in the hypothetical scenarios and comparing the attributes and levels, we can analyze the women's preference of prenatal testing in China. RESULTS: Ninety-two women completed the study. Respondents considered the test procedure as the most important attribute, followed by detection rate, miscarriage rate, wait time for result, and test cost, respectively. The estimated preference weight for the non-invasive procedure was 0.928 (P < 0.0001). All other attributes being equal, the odds of choosing a non-invasive testing procedure over an invasive one was 2.53 (95% confidence interval, 2.42-2.64; P < 0.001). Participants were willing to pay up to RMB$28,810 (approximately US$4610) for a non-invasive test, RMB$6061(US$970) to reduce the miscarriage rate by 1% and up to RMB$3356 (US$537) to increase the detection rate by 1%. Compared to other DCE (Discrete Choice Experiment) studies regarding Down's syndrome screening, women in our study place relatively less emphasis on test safety. CONCLUSIONS: The present study has shown that Chinese women place more emphasis on detection rate than test safety. Chinese women place great preference on noninvasive prenatal testing, which indicate a popular need of incorporating noninvasive prenatal testing into the health insurance coverage in China. This study provided valuable evidence for the decision makers in the Chinese government.


Subject(s)
Abortion, Spontaneous/prevention & control , Choice Behavior , Down Syndrome/diagnosis , Patient Preference/statistics & numerical data , Prenatal Diagnosis/psychology , Abortion, Spontaneous/etiology , Adult , China , Female , Humans , Patient Preference/economics , Patient Preference/psychology , Pregnancy , Prenatal Diagnosis/adverse effects , Prenatal Diagnosis/economics , Prenatal Diagnosis/statistics & numerical data , Surveys and Questionnaires/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL
...